Scott-Edil, visioned by our mentor, Balram Kishan Aggarwal in late 90s, is one of India's fastest growing pharmaceutical company engaged in developing, manufacturing and distributing generic pharmaceuticals products in India and world over in a variety of forms, including syrups, capsules, ointments, oral liquids, tablets, external preparations, dry powder injections and liquid injections. Our products offering includes more than 700 products across several therapeutic segments, including Antibiotics, analgesics, anti-ulcerative, Vitamins and supplements, anti-hypertension, and anti-diabetes amongst others.
As a result of our meticulous planning and marketing , Scott-Edil has conspicuously delivered on all fronts and has expanded its business across multiple growth avenues.
We have diversified our operations across five business divisions:
(i) Generic drugs business: Manufacturing and distribution of generic drugs across various therapies and multiple dosage forms in India through our extensive yet scale and cost-effective distribution network.
(ii) Contract manufacturing business: Supply of finished dosage formulations and pharmaceutical products for the multinational pharmaceutical companies.
(iii) Institution business: Supply of pharmaceutical products for vital institutional supplies primarily State Governments by way of supply contracts/ tenders won on competitive bidding.
(iv) Direct export business: Exporting of finished dosage formulations to key emerging markets including Zimbabwe, Srilanka, Kenya, Tanzania, Vietnam, Cambodia, Syria, Kazakhstan, Nigeria, Congo and Mozambique.
(v) Sale of Active Pharmaceutical Ingredients and other products: Sale of APIs and other products such as dietary protein and food supplements, sachets, dental creams amongst others
Our four manufacturing facilities(including subsidiary) located at Baddi District, Himachal Pradesh are accredited with WHO GMP registrations and are approved in various international markets including Zimbabwe, Kenya, Tanzania, Vietnam, Cambodia, Nigeria, Philippines and Ivory Coast amongst others. We have been awarded certification ensuring compliance with ISO 9001:2008 standards for the manufacturing of tablets, capsules, oral liquid, external preparations, dry syrup, injectable (dry and liquid) and ophthalmics.
We believe that our continuing development initiatives have strengthened our product offerings in the Indian and international markets.
During the last few years, we have entered into partnerships with Abbott, Cipla, German Remedies, Lyka Labs and so forth. These associations are healthy blends of advantage for both sides in manufacturing and marketing nationwide. Abbott has awarded us twice with best business partners for their contract manufacturing business in terms of services and supplies.
Our human resources will continue to be the most valuable asset in this pursuit of leadership and the prime driving force for our growth. We are careful enough not to lose our best assets- The Scottians. They are an essential part of our company and to retain and develop our people, we encourage them to attain a sense of belonging in what they are doing. We can say that it is the people working here that make it different from other organizations. We train our people to improve their skills and knowledge. We believe in the upgrading of our existing human resource rather than appointment of new.